{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:57:17Z","timestamp":1791435437190,"version":"4.3.3"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T00:00:00Z","timestamp":1510704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100016004","name":"Institute of Biomedical Sciences, Academia Sinica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016004","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019225","name":"Taiwan Mouse Clinic","doi-asserted-by":"publisher","award":["105-2325-B-001-010"],"award-info":[{"award-number":["105-2325-B-001-010"]}],"id":[{"id":"10.13039\/501100019225","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST104-2325-B-001-001"],"award-info":[{"award-number":["MOST104-2325-B-001-001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST103-2325-B-001-018"],"award-info":[{"award-number":["MOST103-2325-B-001-018"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 105-2325-B-001-001"],"award-info":[{"award-number":["MOST 105-2325-B-001-001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["AS-102-TP-B13"],"award-info":[{"award-number":["AS-102-TP-B13"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 105-0210-01-13-01"],"award-info":[{"award-number":["MOST 105-0210-01-13-01"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004866","name":"National Research Program for Biopharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004866","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001869","name":"Academia Sinica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001869","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.neo.2017.11.006","type":"journal-article","created":{"date-parts":[[2017,12,13]],"date-time":"2017-12-13T14:02:13Z","timestamp":1513173733000},"page":"119-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["A Low-Toxicity DNA-Alkylating N-Mustard-Quinoline Conjugate with Preferential Sequence Specificity Exerts Potent Antitumor Activity Against Colorectal Cancer"],"prefix":"10.1016","volume":"20","author":[{"given":"Tai-Lin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Bo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Jer","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsann-Long","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ning","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Te-Chang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2017.11.006_bb0005","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/jama.1946.02870380008004","article-title":"Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders","volume":"132","author":"Goodman","year":"1946","journal-title":"JAMA"},{"key":"10.1016\/j.neo.2017.11.006_bb0010","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1021\/cr900208x","article-title":"Introduction to cancer chemotherapeutics","volume":"109","author":"Shewach","year":"2009","journal-title":"Chem Rev"},{"key":"10.1016\/j.neo.2017.11.006_bb0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0165-1110(84)90003-4","article-title":"Relationships between functionality and genetic toxicology of selected DNA-damaging agents","volume":"133","author":"Brendel","year":"1984","journal-title":"Mutat Res"},{"key":"10.1016\/j.neo.2017.11.006_bb0020","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1021\/jm00109a005","article-title":"DNA-directed alkylating agents. 4. 4-anilinoquinoline-based minor groove directed aniline mustards","volume":"34","author":"Gravatt","year":"1991","journal-title":"J Med Chem"},{"key":"10.1016\/j.neo.2017.11.006_bb0025","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1016\/j.bmc.2005.03.057","article-title":"Potent antitumor 9-anilinoacridines bearing an alkylating N-mustard residue on the anilino ring: synthesis and biological activity","volume":"13","author":"Bacherikov","year":"2005","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.neo.2017.11.006_bb0030","doi-asserted-by":"crossref","first-page":"5413","DOI":"10.1016\/j.bmc.2008.04.024","article-title":"Synthesis and biological activity of stable and potent antitumor agents, aniline nitrogen mustards linked to 9-anilinoacridines via a urea linkage","volume":"16","author":"Kapuriya","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.neo.2017.11.006_bb0035","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.bmc.2008.12.022","article-title":"Novel DNA-directed alkylating agents: design, synthesis and potent antitumor effect of phenyl N-mustard-9-anilinoacridine conjugates via a carbamate or carbonate linker","volume":"17","author":"Kapuriya","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.neo.2017.11.006_bb0040","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.bmc.2010.11.005","article-title":"Design, synthesis, and biological evaluation of novel water-soluble N-mustards as potential anticancer agents","volume":"19","author":"Kapuriya","year":"2011","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.neo.2017.11.006_bb0045","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2174\/0929867003373283","article-title":"DNA minor groove alkylating agents","volume":"8","author":"Denny","year":"2001","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.neo.2017.11.006_bb0050","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1021\/jm00166a015","article-title":"DNA-directed alkylating agents. 1. Structure-activity relationships for acridine-linked aniline mustards: consequences of varying the reactivity of the mustard","volume":"33","author":"Gourdie","year":"1990","journal-title":"J Med Chem"},{"key":"10.1016\/j.neo.2017.11.006_bb0055","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1349-7006.2006.00158.x","article-title":"Antitumor activity of sequence-specific alkylating agents: pyrolle-imidazole CBI conjugates with indole linker","volume":"97","author":"Shinohara","year":"2006","journal-title":"Cancer Sci"},{"key":"10.1016\/j.neo.2017.11.006_bb0060","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/nrc749","article-title":"DNA and its associated processes as targets for cancer therapy","volume":"2","author":"Hurley","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.neo.2017.11.006_bb0065","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.bmc.2010.01.061","article-title":"Potent DNA-directed alkylating agents: synthesis and biological activity of phenyl N-mustard-quinoline conjugates having a urea or hydrazinecarboxamide linker","volume":"18","author":"Kakadiya","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.neo.2017.11.006_bb0070","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.3748\/wjg.v13.i28.3806","article-title":"Metastatic colorectal cancer\u2014past, progress and future","volume":"13","author":"Field","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.neo.2017.11.006_bb0075","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3747\/co.v18i1.708","article-title":"Oxaliplatin: a review in the era of molecularly targeted therapy","volume":"18","author":"Alcindor","year":"2011","journal-title":"Curr Oncol"},{"key":"10.1016\/j.neo.2017.11.006_bb0080","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.2005.03.0106","article-title":"OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-go fashion in advanced colorectal cancer--a GERCOR study","volume":"24","author":"Tournigand","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.neo.2017.11.006_bb0085","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1056\/NEJMoa032709","article-title":"Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer","volume":"350","author":"Andre","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.neo.2017.11.006_bb0090","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.neo.2017.11.006_bb0095","first-page":"428","article-title":"American Cancer Society colorectal cancer survivorship care guidelines","volume":"65","author":"El-Shami","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.neo.2017.11.006_bb0100","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ab.2007.10.008","article-title":"Preferred binding sites for the bifunctional intercalator TANDEM determined using DNA fragments that contain every symmetrical hexanucleotide sequence","volume":"374","author":"Hampshire","year":"2008","journal-title":"Anal Biochem"},{"key":"10.1016\/j.neo.2017.11.006_bb0105","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.biochi.2008.01.001","article-title":"The effects of local DNA sequence on the interaction of ligands with their preferred binding sites","volume":"90","author":"Hampshire","year":"2008","journal-title":"Biochimie"},{"key":"10.1016\/j.neo.2017.11.006_bb0110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ymeth.2007.01.002","article-title":"Footprinting: a method for determining the sequence selectivity, affinity and kinetics of DNA-binding ligands","volume":"42","author":"Hampshire","year":"2007","journal-title":"Methods"},{"key":"10.1016\/j.neo.2017.11.006_bb0115","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00285-005-0357-z","article-title":"A fast algorithm for the construction of universal footprinting templates in DNA","volume":"52","author":"Anderson","year":"2006","journal-title":"J Math Biol"},{"key":"10.1016\/j.neo.2017.11.006_bb0120","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neo.2016.02.005","article-title":"A potent derivative of indolizino[6,7-b]indole for treatment of human non\u2013small cell lung cancer cells","volume":"18","author":"Chen","year":"2016","journal-title":"Neoplasia"},{"key":"10.1016\/j.neo.2017.11.006_bb0125","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1593\/neo.10110","article-title":"Combination of bifunctional alkylating agent and arsenic trioxide synergistically suppresses the growth of drug-resistant tumor cells","volume":"12","author":"Lee","year":"2010","journal-title":"Neoplasia"},{"key":"10.1016\/j.neo.2017.11.006_bb0130","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1101\/gr.849004","article-title":"WebLogo: a sequence logo generator","volume":"14","author":"Crooks","year":"2004","journal-title":"Genome Res"},{"key":"10.1016\/j.neo.2017.11.006_bb0135","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(95)90696-7","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.neo.2017.11.006_bb0140","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.neo.2017.11.006_bb0145","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s11095-010-0189-4","article-title":"Pharmacokinetics and toxicodynamics of oxaliplatin in rats: application of a toxicity factor to explain differences in the nephrotoxicity and myelosuppression induced by oxaliplatin and the other platinum antitumor derivatives","volume":"27","author":"Hanada","year":"2010","journal-title":"Pharm Res"},{"key":"10.1016\/j.neo.2017.11.006_bb0150","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0304-3835(85)90102-8","article-title":"Antitumor activity of l-OHP in mice","volume":"27","author":"Mathe","year":"1985","journal-title":"Cancer Lett"},{"key":"10.1016\/j.neo.2017.11.006_bb0155","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0022-3565(25)32105-1","article-title":"Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations","volume":"213","author":"Dobyan","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neo.2017.11.006_bb0160","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1093\/nar\/14.7.2971","article-title":"DNA-sequence selectivity of guanine-N7 alkylation by nitrogen mustards","volume":"14","author":"Mattes","year":"1986","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.neo.2017.11.006_bb0165","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1021\/cr980421n","article-title":"Structure, recognition, and processing of cisplatin-DNA adducts","volume":"99","author":"Jamieson","year":"1999","journal-title":"Chem Rev"},{"key":"10.1016\/j.neo.2017.11.006_bb0170","doi-asserted-by":"crossref","first-page":"10531","DOI":"10.1093\/nar\/15.24.10531","article-title":"Mechanisms of DNA sequence selective alkylation of guanine-N7 positions by nitrogen mustards","volume":"15","author":"Kohn","year":"1987","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.neo.2017.11.006_bb0175","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.neo.2017.11.006_bb0180","doi-asserted-by":"crossref","first-page":"13034","DOI":"10.1021\/bi00040a014","article-title":"Sequence specificity of alkylation for a series of nitrogen mustard-containing analogues of distamycin of increasing binding site size: evidence for increased cytotoxicity with enhanced sequence specificity","volume":"34","author":"Wyatt","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.neo.2017.11.006_bb0185","first-page":"187","article-title":"Sequence selectivity, cross-linking efficiency and cytotoxicity of DNA-targeted 4-anilinoquinoline aniline mustards","volume":"14","author":"McClean","year":"1999","journal-title":"Anticancer Drug Des"},{"key":"10.1016\/j.neo.2017.11.006_bb0190","doi-asserted-by":"crossref","first-page":"G223","DOI":"10.1152\/ajpgi.00212.2014","article-title":"Platinum-based chemotherapy: gastrointestinal immunomodulation and enteric nervous system toxicity","volume":"308","author":"Stojanovska","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558617303822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558617303822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:59:59Z","timestamp":1778615999000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558617303822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1476558617303822"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2017.11.006","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Low-Toxicity DNA-Alkylating N-Mustard-Quinoline Conjugate with Preferential Sequence Specificity Exerts Potent Antitumor Activity Against Colorectal Cancer","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2017.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.","name":"copyright","label":"Copyright"}]}}